Overview
- Editors:
-
-
M. A. Hayat
-
Department of Biological Sciences, Kean University, Union, USA
- The only book that discusses cancer diagnosis, therapy, and prognosis together in one volume
- Discusses the molecular processes that lead to the development and proliferation of cancer cells
- Recent major advances in cancer diagnosis and therapy are included
- The text is supported throughout with illustrations
- The information identifies patients with high likelihood of clinical benefits from a specific treatment
Access this book
Other ways to access
Table of contents (22 chapters)
-
Front Matter
Pages i-xxxi
-
Gastrointestinal Cancers
-
-
- Jacqueline Duffour, Olivier Bouché, Philippe Rougier, Chantal Milan, Laurent Bedenne, Jean-François Seitz et al.
Pages 13-21
-
-
-
-
- Martin Gotthardt, Thomas M. Behr, Martin Béhé
Pages 43-52
-
Esophageal Cancer
-
- Domenico Rubello, Cristina Nanni
Pages 55-61
-
- Kanwar Rupinder S. Gill, Timothy A. Woodward
Pages 63-75
-
- Hideyuki Ishiguro, Yoshiyuki Kuwabara, Nobuyoshi Sugito, Yoshitaka Fujii
Pages 77-81
-
- Lana Y. Schumacher, Nicole B. Baril, Sherry M. Wren
Pages 83-95
-
Gastric Cancer
-
- Levente Ficsor, Bela Molnar
Pages 99-111
-
- Hiroshi Yokozaki, Tadateru Hasuo, Shin-ya Satake, Yasuhiro Omori, Naoko Maeda, Korefumi Nakamura et al.
Pages 113-120
-
- Halagowder Devaraj, A. Anand Kumar, Niranjali Devaraj
Pages 121-136
-
- Akiko Shiotani, Ken Haruma, David Y. Graham
Pages 137-151
-
-
- Seigo Kitano, Kazuhiro Yasuda, Norio Shiraishi
Pages 163-170
-
- Yoshihiro Kakeji, Eiji Oki, Noriaki Sadanaga, Masaru Morita, Yoshihiko Maehara
Pages 171-180
-
Pancreatic Cancer
-
- Yasuhiko Tomita, Hirokazu Uyama, Hideji Nakamura
Pages 183-189
-
About this book
Each year, tens of millions of people are respectively. The following data indicate diagnosed worldwide with cancer, and the burden (seriousness) of gastrointestinal more than half of these patients eventu- cancer, liver cancer, and colorectal cancers ally die from this disease. The severity of globally and in the United States. (Table 1) the burden of cancer becomes really clear Surgical and molecular therapies and pr- by knowing that there were ? 10, 862, 496 nostic markers for gastrointestinal stromal new cancer cases (excluding skin cancer) tumors are discussed in this volume. Role in the world in 2002, and the number of of anticancer drugs and monoclonal an- deaths caused by this disease in the same bodies specific for these tumors are also year was ? 6,723,887 (GLOBOCAN). discussed. Imaging modality assessing the The number of deaths due to cancer in the effect of anticancer imatinib on these tumors United States was estimated to be 559, 650 is included. Diagnostic and prognostic (Am. Cancer Soc. ). Cancer is caused by markers of clinical outcomes using che- both external factors (tobacco, chemicals, therapy and hormone replacement therapy radiation, and infectious organisms) and for gastric adenocarcinoma are detailed. internal factors (inherited mutations, hor- Also, are discussed immunohistochem- mones, immune conditions, and mutations try of esophageal cancer progression, and that occur from metabolism). diagnostic and therapeutic methodologies All cancer types caused by cigarette for biliary tumors.
Editors and Affiliations
-
Department of Biological Sciences, Kean University, Union, USA
M. A. Hayat